MENU
CING
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cingulate (CING) Ownership - Who owns Cingulate?
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes... Show more
Profile
Industry
N/A
Address
1901 West 47th Place
Phone
+1 913 942-2300
Employees
13
Web
https://www.cingulate.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
17.45M
P/E Ratio
N/A
Total Cash
9.52M
Projected Growth
N/A
Total Debt
5.08M
Revenue
N/A
Risk (Beta)
-1.62
Dividend Yield
N/A
Total Cash/Share
2.24
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CING
Capitalization
17.4M
P/E Ratio
N/A
Risk (Beta)
-1.62
Dividend Yield
N/A
Total Cash
9.52M
Total Cash/Share
2.24
Total Debt
5.08M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
5.93M
P/B Ratio
2.92
Cash Flow
N/A
Earnings
-4.03
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
382
Current Ratio
1.87
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-15.75M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-182.32
Shares Held By Institutions
658K
Shares Outstanding - Current
4.25M
Total Liabilities
6.54M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-17.241
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1901 West 47th Place
Phone
+1 913 942-2300
Employees
13
Web
https://www.cingulate.com